Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Lilja

Showing results (51-60 of 306) with videos related to

Pageof 31
Sort By:
Analytica Chimica Acta|January 1, 2018
Reducing WBC background in cancer cell separation products by negative acoustic contrast particle immuno-acoustophoresisKevin Cushing, Eva Undvall, Yvonne Ceder, et al.
Journal of Andrology|October 26, 2002
Exogenous protein kinases A and C, but not endogenous prostasome-associated protein kinase, phosphorylate semenogelins I and II from human semenPia Ek, Johan Malm, Hans Lilja, et al.
European Urology|August 29, 2006
Prostate cancer screening decreases the absolute risk of being diagnosed with advanced prostate cancer--results from a prospective, population-based randomized controlled trialGunnar Aus, Svante Bergdahl, Pär Lodding, et al.
Clinical Chemistry|July 27, 2002
Sensitive and specific enzymatic assay for the determination of precursor forms of prostate-specific antigen after an activation stepPauliina Niemelä, Janita Lövgren, Matti Karp, et al.
The Prostate|June 11, 2005
Assessment of intra-individual variation in prostate-specific antigen levels in a biennial randomized prostate cancer screening program in SwedenLaila Bruun, Charlotte Becker, Jonas Hugosson, et al.
The Journal of Urology|September 23, 2003
Testing in serum for human glandular kallikrein 2, and free and total prostate specific antigen in biannual screening for prostate cancerCharlotte Becker, Timo Piironen, Kim Pettersson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Systematic review of pretreatment prostate-specific antigen velocity and doubling time as predictors for prostate cancerAndrew J Vickers, Caroline Savage, M Frank O'Brien, et al.
Urology|February 7, 2016
The Memorial Sloan Kettering Cancer Center Recommendations for Prostate Cancer ScreeningAndrew J Vickers, James A Eastham, Peter T Scardino, et al.
Cancer|March 26, 2004
Results of a randomized, population-based study of biennial screening using serum prostate-specific antigen measurement to detect prostate carcinomaJonas Hugosson, Gunnar Aus, Hans Lilja, et al.
Urology|June 6, 2016
Reply to Re: The Memorial Sloan Kettering Cancer Center Recommendations for Prostate Cancer ScreeningAndrew J Vickers, James A Eastham, Peter T Scardino, et al.
Pageof 31

Showing results (51-60 of 306) with videos related to

Sort By:
Pageof 31
Analytica Chimica Acta|January 1, 2018
Reducing WBC background in cancer cell separation products by negative acoustic contrast particle immuno-acoustophoresisKevin Cushing, Eva Undvall, Yvonne Ceder, et al.
Journal of Andrology|October 26, 2002
Exogenous protein kinases A and C, but not endogenous prostasome-associated protein kinase, phosphorylate semenogelins I and II from human semenPia Ek, Johan Malm, Hans Lilja, et al.
European Urology|August 29, 2006
Prostate cancer screening decreases the absolute risk of being diagnosed with advanced prostate cancer--results from a prospective, population-based randomized controlled trialGunnar Aus, Svante Bergdahl, Pär Lodding, et al.
Clinical Chemistry|July 27, 2002
Sensitive and specific enzymatic assay for the determination of precursor forms of prostate-specific antigen after an activation stepPauliina Niemelä, Janita Lövgren, Matti Karp, et al.
The Prostate|June 11, 2005
Assessment of intra-individual variation in prostate-specific antigen levels in a biennial randomized prostate cancer screening program in SwedenLaila Bruun, Charlotte Becker, Jonas Hugosson, et al.
The Journal of Urology|September 23, 2003
Testing in serum for human glandular kallikrein 2, and free and total prostate specific antigen in biannual screening for prostate cancerCharlotte Becker, Timo Piironen, Kim Pettersson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Systematic review of pretreatment prostate-specific antigen velocity and doubling time as predictors for prostate cancerAndrew J Vickers, Caroline Savage, M Frank O'Brien, et al.
Urology|February 7, 2016
The Memorial Sloan Kettering Cancer Center Recommendations for Prostate Cancer ScreeningAndrew J Vickers, James A Eastham, Peter T Scardino, et al.
Cancer|March 26, 2004
Results of a randomized, population-based study of biennial screening using serum prostate-specific antigen measurement to detect prostate carcinomaJonas Hugosson, Gunnar Aus, Hans Lilja, et al.
Urology|June 6, 2016
Reply to Re: The Memorial Sloan Kettering Cancer Center Recommendations for Prostate Cancer ScreeningAndrew J Vickers, James A Eastham, Peter T Scardino, et al.
Pageof 31